Effects of Play Based Therapy on Attention Level of Children With Down Syndrome
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Mar 19, 2025
Trial Information
Current as of May 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how play-based therapy affects the attention levels of children with Down syndrome. Researchers want to see if this type of therapy helps improve focus in young children compared to another approach called child-centered play therapy. The study will include children aged 3 to 5 years who are currently participating in speech therapy with their parents involved in the process. To be part of the study, children must be healthy enough to participate without any serious health issues or conditions that could interfere with the results.
While the trial is not yet recruiting participants, it aims to help understand the benefits of play in therapy for children with Down syndrome. If your child is eligible, they will engage in fun play activities designed to enhance their attention skills. This study could contribute valuable insights into how different types of therapy can support children with Down syndrome in improving their focus and overall development.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age: 3-5 years
- • Gender: Both male and female
- • Children who are currently taking speech therapy sessions with parental involvement.
- • Medically stable children with no severe ongoing health issues that could interfere with their participation in the study.
- Exclusion Criteria:
- • Children with severe sensory impairments
- • Co-morbid neurological conditions that may confound the results
- • Children who received intervention from any other institute
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Aleena Irum, Ms-SLP
Principal Investigator
Riphah International University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported